Emmanuel Acha Asongalem
University of Buea
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Emmanuel Acha Asongalem.
BMC Complementary and Alternative Medicine | 2011
Jules Cn Assob; Henri L. Kamga; Anna Longdoh Njunda; Peter F Nde; Emmanuel Acha Asongalem; Abdel Jelil Njouendou; Bertrand Sandjon; Veronique B Penlap
BackgroundInfectious diseases caused by multiresistant microbial strains are on the increase. Fighting these diseases with natural products may be more efficacious. The aim of this study was to investigate the in vitro antimicrobial activity of methanolic, ethylacetate (EtOAc) and hexanic fractions of five Cameroonian medicinal plants (Piptadeniastum africana, Cissus aralioides, Hileria latifolia, Phyllanthus muellerianus and Gladiolus gregasius) against 10 pathogenic microorganisms of the urogenital and gastrointestinal tracts.MethodsThe fractions were screened for their chemical composition and in vivo acute toxicity was carried out on the most active extracts in order to assess their inhibitory selectivity.The agar well-diffusion and the micro dilution methods were used for the determination of the inhibition diameters (ID) and Minimum inhibitory concentrations (MIC) respectively on 8 bacterial species including two Gram positive species (Staphylococcus aureus, Enterococcus faecalis), and six Gram negative (Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, Proteus mirabilis, Shigella flexneri, Salmonella typhi) and two fungal isolates (Candida albicans, Candida krusei). The chemical composition was done according to Harbone (1976), the acute toxicity evaluation according to WHO protocol and the hepatic as well as serum parameters measured to assess liver and kidney functions.ResultsThe chemical components of each plants extract varied according to the solvent used, and they were found to contain alkaloids, flavonoids, polyphenols, triterpens, sterols, tannins, coumarins, glycosides, cardiac glycosides and reducing sugars. The methanolic and ethylacetate extracts of Phyllanthus muellerianus and Piptadeniastum africana presented the highest antimicrobial activities against all tested microorganisms with ID varying from 8 to 26 mm and MIC from 2.5 to 0.31 mg/ml. The in vivo acute toxicity study carried out on the methanolic extracts of Phyllanthus muellerianus and Piptadeniastrum africana indicated that these two plants were not toxic. At the dose of 4 g/kg body weight, kidney and liver function tests indicated that these two medicinal plants induced no adverse effect on these organs.ConclusionThese results showed that, all these plants extracts can be used as antimicrobial phytomedicines which can be therapeutically used against infections caused by multiresistant agents.Phyllanthus muellerianus, Piptadeniastum africana, antimicrobial, acute toxicity, kidney and liver function tests, Cameroon Traditional Medicine
African Journal of Laboratory Medicine | 2016
Asa'ah Nkohkwo; Gabriel A. Agbor; Emmanuel Acha Asongalem; Claude Tagny; Tazoacha Asonganyi
Background Despite vast improvements in transfusion services in sub-Saharan Africa over the last decade, there remain serious concerns on the safety and adequacy of the blood supply across the region. Objective This review paper ascertains the role of pathogen reduction technology (PRT) in improving blood safety and supply adequacy in the region. Method The state of blood safety in sub-Saharan Africa was reviewed. Meetings, seminars and correspondence were undertaken with key clinicians, scientists and professional bodies in the region, including the World Health Organization’s Regional Office for Africa, to examine the suitability of PRT for improving the safety of whole blood transfusion, a prevalent transfusion format in the region. Results Existing literature suggests that combining PRT with current blood safety measures (such as serology) would improve the safety and adequacy of the blood supply for transfusions in sub-Saharan Africa. This was echoed by the findings of the stakeholder meetings. Conclusion Following a detailed appraisal of two leading PRT systems, the Mirasol® PRT System and the Cerus S-303 System, we suggest that companies conduct comprehensive toxicological evaluation of the agents used for PRT and publish this in the scientific literature. We also recommend that the safety and efficacy of these technologies should be established in a randomised clinical trial conducted in sub-Saharan Africa.
Methods and Findings in Experimental and Clinical Pharmacology | 2008
Emmanuel Acha Asongalem; Paulin Nana; Harquin Simplice Foyet; Théophile Dimo; Pierre Kamtchouing
Acanthus montanus T. Anderson (Acanthaceae) possesses several medicinal properties; it is used in Cameroon as a folk medicine to treat pain, inflammation and threatened abortion. The aim of this study was to determine the effect of A. montanus aqueous extract on the estrous cycle pre- and postimplantation in rats and its mechanism of action. The estrous cycles of Wistar rats were monitored before, during and after oral administration of distilled water (control) or aqueous extract (62.5, 125, 250, 500, 1000 mg/kg/day). Furthermore, pregnant rats received the above doses of aqueous extract on days 1-6 (preimplantation) or 6-15 (postimplantation) of gestation and were sacrificed on day 8 or 20 of pregnancy, respectively. Moreover, aqueous extract (500 and 1000 mg/kg/day) was given to ovariectomized rats in the presence or absence of exogenously administered estrogen and/or progesterone and uterine weight and deciduoma count were evaluated. The extract, irrespective of dose, reversibly prolonged the metestrous and occasionally the diestrous stages of the estrous cycle. The extract did not alter the uterine wet weight or deciduoma count, suggesting a lack of estrogenic and progestational effects. At 1000 mg/kg/day, the extract caused appreciable preimplantation losses of 36.8 +/- 6.5% (P < 0.05), while none of the doses caused postimplantation losses. The extract also caused delayed fetal growth.
African Journal of Traditional, Complementary and Alternative Medicines | 2008
Léonard Tédong; Paul Désiré Djomeni Dzeufiet; Théophile Dimo; Emmanuel Acha Asongalem; Selestin Ndogmo Sokeng; Jean-François Flejou; Patrice Callard; Pierre Kamtchouing
African Journal of Traditional, Complementary and Alternative Medicines | 2007
Paul Désiré Djomeni Dzeufiet; Dieudonné Y. Ohandja; Léonard Tédong; Emmanuel Acha Asongalem; Théophile Dimo; Pierre Kamtchouing
Archive | 2006
Harquin Simplice Foyet; Emmanuel Acha Asongalem; Paulin Nana; Pierre Kamtchouing
Journal of Ethnopharmacology | 2004
Emmanuel Acha Asongalem; Harquin Simplice Foyet; Same Ekobo; Théophile Dimo; Pierre Kamtchouing
HEALTH SCIENCES AND DISEASES | 2015
Emmanuel Acha Asongalem; Gottlieb Lobe Monekosso; Leonard Ambindei Mbam
BMC Research Notes | 2017
Renda Colins Yekabong; Walter Akoh Ebile; Peter Nde Fon; Emmanuel Acha Asongalem
BMC Complementary and Alternative Medicine | 2017
Harquin Simplice Foyet; Serge Tchinda Deffo; Pascaline Koagne Yewo; Iulia Antioch; Stéphane Zingue; Emmanuel Acha Asongalem; Pierre Kamtchouing; Alin Ciobica